Q32 Bio (QTTB) Change in Cash (2017 - 2026)
Q32 Bio (QTTB) recorded quarterly Change in Cash of $2.5 million in Q1 2026, up 430.73% quarter-over-quarter from -$742000.0 in Q4 2025, and up 119.66% on a YoY basis from $1.1 million in Q1 2025.
Q32 Bio (QTTB) Change in Cash (2017 - 2026) Analysis & Trends
Q32 Bio's Change in Cash history runs 10 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- In Q1 2026, Change in Cash rose 119.66% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at -$14.7 million (up 70.55% YoY), while the FY2025 annual figure was -$29.7 million, down 162.66% from the prior year.
- Change in Cash was $2.5 million for Q1 2026 at Q32 Bio, up from -$742000.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $138.1 million in Q1 2022 to a low of -$133.0 million in Q3 2022.
- Historically, Change in Cash has averaged -$4.4 million across 5 years, with a median of -$10.6 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Change in Cash plunged 707.0% in 2022, then surged 779.9% in 2024.
- A 5-year view of Change in Cash shows it stood at -$9.2 million in 2022, then dropped by 15.94% to -$10.6 million in 2023, then fell by 4.46% to -$11.1 million in 2024, then soared by 93.32% to -$742000.0 in 2025, then jumped by 430.73% to $2.5 million in 2026.
- The last three Change in Cash figures came in at $2.5 million (Q1 2026), -$742000.0 (Q4 2025), and -$5.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -45.97 Mn |
| 10 | Q32 Bio | 177.18 Mn | 126.43 Mn | - | 2.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.45 Mn |
| Dec 31, 2025 | -742,000.00 |
| Sep 30, 2025 | -5.79 Mn |
| Jun 30, 2025 | -10.65 Mn |
| Mar 31, 2025 | -12.48 Mn |
| Dec 31, 2024 | -11.11 Mn |
| Sep 30, 2024 | -8.58 Mn |
| Jun 30, 2024 | -17.85 Mn |
| Mar 31, 2024 | 84.89 Mn |
| Dec 31, 2023 | -10.64 Mn |
| Sep 30, 2023 | 16.20 Mn |
| Jun 30, 2023 | -11.35 Mn |
| Mar 31, 2023 | -12.49 Mn |
| Dec 31, 2022 | -9.18 Mn |
| Sep 30, 2022 | -133.03 Mn |
| Jun 30, 2022 | -72.22 Mn |
| Mar 31, 2022 | 138.07 Mn |
| Dec 31, 2021 | 13.23 Mn |
| Sep 30, 2021 | -20.48 Mn |
| Jun 30, 2021 | 11.90 Mn |